I don't know just how much, but there's definitely gonna be degradation in the liver. And it'll be particularly bad because anything administered orally, then swallowed passes the liver twice. If you're gonna try it I suggest you mix an open capsule with 1 ml water and, hold that under your tongue for a minimum of 20 seconds. Sublinguals, transdermals, and injectables only take a single liver pass. And for that ridiculous price I can buy 3 5 mg lyophilized powder vials. So that's reconstituted, then injected with an insulin syringe. MZ store has some great stuff, but I'd save my money, if I were you.
I did find this, though: "
As it has been observed to have a more localized, proximate healing effect, it has been hypothesized that BPC-157 may have a substantial beneficial impact when administered orally on injuries suffered in the gastrointestinal system.
Further, as other studies have illuminated the peptide’s positive impact on healing regarding the “brain-gut” axis, regenerative effects resulting from the oral route have also been hypothesized to extend to neuroprotection and healing as well.
But can it still be effective in healing musculoskeletal injuries when given orally?
Successful Application of BPC-157 For Oral Use
To date, several clinical studies conducted using rat test subjects have observed the effects of both parenteral administration (injection) of BPC-157 as well as oral administration.
Generally, these studies have yielded promising results,
with oral administration observed to be significantly effective.
For example, oral delivery has been observed to provide measurable neuroprotective effects in rat test subjects exposed to cuprizone (a neurotoxin). Likewise, ancillary research suggests that the peptide’s influence in the brain-gut axis may be responsible for these benefits as well.
It is important to note that at this time, studies have only been conducted using rodent subjects and not performance animals like greyhounds or horses.
However, to be clear,
several clinical studies have given strong evidence for the efficacy of BPC-157 when administered orall"
University texts: http://jpp.krakow.pl/journal/archive/04_10/pdf/241_04_10_article.pdf
onlinelibrary.wiley.com
Haha, and this is funny if you know what a fistula is!
Rectovaginal fistula is a devastating condition providing more than 99% of patients for surgical treatment. We hypothesized that rectovaginal fistula …
www.sciencedirect.com